Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature

Omalizumab is a recombinant humanized monoclonal antibody that blocks the high-affinity Fc receptor of IgE. Omalizumab has been approved for the treatment of moderate to severe asthma; however, there is currently more and more data showing promising results in the management also of chronic urticari...

Full description

Bibliographic Details
Main Authors: Ilya Ivyanskiy, Carsten Sand, Simon Francis Thomsen
Format: Article
Language:English
Published: Karger Publishers 2012-01-01
Series:Case Reports in Dermatology
Subjects:
Omalizumab
Anti-IgE
Chronic urticaria
Biologics
Online Access:http://www.karger.com/Article/FullText/336205

Similar Items

Similar Items